'XE variant of Covid-19 not more severe than Omicron': Dr Gagandeep Kang

Variants will come because people are travelling. Of what we know of the variant (XE) is that it is not a point of concern, Kang said

Gagandeep Kang
Dr Gagandeep Kang, Professor at Christian Medical College in Vellore
Press Trust of India New Delhi
3 min read Last Updated : Apr 07 2022 | 10:24 PM IST

The new XE variant of Covid-19 is not a matter of concern as it is not likely to cause any more severity than other sub-variants of Omicron (BA.1 and BA.2) did, Dr Gagandeep Kang, Professor at Christian Medical College in Vellore, said on Thursday.

Variants will come because people are travelling. Of what we know of the variant (XE) is that it is not a point of concern, Kang said.

We were worried about BA.2 but it did not cause more serious disease than BA.1. XE does not cause more serious disease than BA.1 or BA.2, she said on the sidelines of a panel discussion organised by John Hopkins Gupta-Klinsky India Institute here.

She added that in a vaccinated population XE variant is not something to be bothered about.

The World Health Organisation (WHO) has issued warning against XE, a new variant of Omicron first detected in the UK.

It has suggested that it could be more transmissible than any Covid strain so far. XE is a combination or recombinant of both sub-variants (BA.1 and BA.2) of Omicron.

The Brihanmumbai Municipal Corporation (BMC) has said it has detected the first case of XE infection in Mumbai.

However, the Union Health Ministry said that the sample which is being said to be 'XE' variant was analysed in detail by genome experts of the Indian SARS-CoV-2 Genomics Consortium (INSACOG), who have inferred that the genomic constitution of this variant does not correlate with the genomic constitution of XE variant.

When asked about her views on administering booster dose to population below 60 years, Kang said that the country doesn't have enough data to establish the effectiveness of booster doses among people younger than 60 years.

Director General, Indian Council of Medical Research (ICMR), Dr Balram Bhargava echoed a similar view on booster dose and said, I agree with Dr Kang.

The panel discussion was held on the theme Applying Lessons Learned from COVID for a Stronger Health System'.

Speaking during the panel discussion, Dr Bhargava said that the greatest thing India learnt from Covid was that it became self confident.

We got self-confidence that our health care system can deliver, he said.

He acknowledged that there was a need to strengthen the primary healthcare system to tackle such situations in future.

We need to invest more in primary health care system and impart good training which is much needed. We need good MBBS doctors with proper raining, Bhargava said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusOmicronGagandeep KangWorld Health OrganizationICMR

First Published: Apr 07 2022 | 10:24 PM IST

Next Story